Kevin Dines

Company: Bristol Myers Squibb

Job title: Scientific Senior Director, Preclinical Sciences

Seminars:

Roundtable Discussion: Comparing Neuroinflammatory Biomarker Development Across Different Neurological Diseases 11:30 am

One of the biggest challenges in developing neuroimmunology drugs is distinguishing between the underlying CNS pathologies and inflammatory subtypes that vary across different neurological conditions. For this session, attendees will be organized into several roundtables, each discussing how biomarkers are currently being developed to detect neuroinflammation in one of the following neurological indications: Alzheimer’s, Parkinson’s,…Read more

day: Conference Day Two

Panel Discussion: Leveraging In Vivo Neuroimmune Modelling to Streamline Translation into the Clinic 2:45 pm

Assessing the value of current in vivo models to help understand neuroinflammatory disease progression Discussing how to select activating agents specific to the inflammatory pathway of interest Harnessing in vivo models to confirm whether a drug is having therapeutic effects within the CNSRead more

day: Conference Day Two